ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $31,000 | -56.3% | 61,157 | -37.0% | 0.00% | – |
Q2 2020 | $71,000 | +36.5% | 97,138 | +83.3% | 0.00% | – |
Q1 2020 | $52,000 | -92.6% | 53,001 | -84.4% | 0.00% | -100.0% |
Q4 2019 | $703,000 | -45.8% | 340,708 | -23.3% | 0.00% | -66.7% |
Q3 2019 | $1,297,000 | -31.2% | 444,263 | +78.3% | 0.00% | -25.0% |
Q2 2019 | $1,886,000 | -29.9% | 249,203 | +22.6% | 0.00% | -20.0% |
Q1 2019 | $2,691,000 | +65.7% | 203,268 | +92.6% | 0.01% | +25.0% |
Q4 2018 | $1,624,000 | +60.8% | 105,523 | +105.3% | 0.00% | +100.0% |
Q3 2018 | $1,010,000 | -11.8% | 51,389 | +28.8% | 0.00% | 0.0% |
Q2 2018 | $1,145,000 | +10.3% | 39,891 | -9.1% | 0.00% | 0.0% |
Q1 2018 | $1,038,000 | +4.8% | 43,891 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $990,000 | -7.0% | 43,891 | -2.4% | 0.00% | 0.0% |
Q3 2017 | $1,064,000 | +5.8% | 44,991 | -11.9% | 0.00% | 0.0% |
Q2 2017 | $1,006,000 | -13.1% | 51,091 | -7.3% | 0.00% | 0.0% |
Q1 2017 | $1,157,000 | +5.7% | 55,104 | -7.7% | 0.00% | 0.0% |
Q4 2016 | $1,095,000 | – | 59,691 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |